
KKR · NYSE
The supplied consensus is Buy across 16 analysts, with a mean price target of $125. The low and high targets are not provided, so the target spread cannot be measured, and the evidence identifies neither the most bullish nor least bullish analyst. No named analyst or brokerage rating action appears in the supplied material, leaving the direction of revisions over the past week unreported. The substantive debate visible in the research is operational rather than target-specific: bulls emphasize KKR’s record second-quarter performance, AUM growth, management fees, fundraising, deployment, and monetization, while bears can point to higher expenses and the decline in FY2025 revenue and net income. The supplied evidence does not establish a separate valuation disagreement.